MAGIC trial infographic – APF530 in three-drug regimen for CINV

Following the publication of the results of the Phase III MAGIC trial in Future Oncology – available here – we’ve summarized some of the key trial data in the infographic below. Scroll down to learn more about the efficacy of APF530 for the treatment of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please Login or Register to view this area.